Compromised vitamin D status is common in pregnancy and may have adverse impacts on fetal development. The purpose of this study was to investigate the association of infant whole-body bone mineral content (WBBMC) at 8-21 days of age with feto-maternal vitamin D status in a multiethnic population in Oakland, California. SUBJECTS/METHODS: This was a cross-sectional study of 120 women and their newborn infants. Maternal and cord blood were collected at delivery. WBBMC was measured by dual-energy X-ray absorptiometry in term-born infants 8-21days post birth. RESULTS: No significant association was observed between unadjusted or size-adjusted WBBMC and feto-maternal vitamin D status analyzed continuously or categorically. In multivariate modeling, unadjusted WBBMC was predicted by bone area (Po0.0001), weight-for-age (Po0.0001) and weight-for-length (P ¼ 0.0005) Z-scores, but not by feto-maternal vitamin D status. Anthropometric predictors but not vitamin D remained significant in the multivariate model after adjustment of WBBMC for weight, bone area (bone mineral density) or logarithmically derived exponents of the denominators. CONCLUSIONS: Results of the present study do not support an association between feto-maternal vitamin D status and early infant WBBMC, raw or adjusted for inter-individual differences in size, in a multiethnic population in Northern California.
INTRODUCTION
Fetal bone mineralization is determined by placental mineral transfer and fetal bone turnover, with maternal nutrient status, disease and conditions affecting placental transfer having possible impacts on fetal bone. 1 Bone mineralization and growth during fetal development and early infancy may have implications for childhood growth and development, peak bone mass and later risk for osteoporosis. 2, 3 Vitamin D, which in its biologically active form 1,25(OH) 2 D acts as a potent genetic regulator, may influence fetal bone accretion by upregulating expression of genes encoding rate-limiting placental calcium transport proteins (plasma membrane calcium ATPase1-4). 4 Maternal vitamin D status, especially during the third trimester of gestation, has been associated with neonatal bone growth or mineralization in some studies [5] [6] [7] but not in others. 8 In adults, the relationship between serum 25(OH)D and bone mineral density (BMD) varies among Caucasians, African Americans and Hispanics. 9 A single study with limited sample size (n ¼ 50) has previously investigated feto-maternal vitamin D status and infant whole-body bone mineral content (WBBMC) in the first 2 weeks of life. 10 Oakland, California hosts a racially diverse population, with skin color and genetic variance affecting maternal vitamin D status and possibly fetal bone mineralization. The purpose of the present study was to investigate the relation between feto-maternal vitamin D status and WBBMC at 8-21 days of age in a multiethnic population in Oakland, CA (381N).
SUBJECTS AND METHODS
The study was approved by the institutional review boards of the University of California, Davis, Children's Hospital & Research Center, Oakland and Alta Bates Medical Center, Berkeley. Recruitment took place between December 2006 and January 2008. Study subjects were mothers obtaining perinatal care at East Bay Perinatal Medical Associates in Oakland, CA and their infants. Women who were 18-45 years of age and carrying a singleton fetus were eligible for recruitment and infants born at term (37-42 weeks of gestation) with dual-energy X-ray absorptiometry (DXA) scans between 8 and 21 days were included in analysis. Informed consent was obtained from all the mothers upon study enrollment during weeks 34-40 of gestation.
An interviewer-administered questionnaire was used to evaluate intake and lifestyle factors related to vitamin D status as described previously.
11
Medical records were reviewed to ascertain pre-or early-pregnancy weight, length of gestation, pregnancy and delivery events, and infant birth weight. Pre-gestational maternal body mass index (BMI) was calculated from reported height and pre-or early-pregnancy weight recorded in the medical file.
Maternal venous blood was collected upon admission to the Alta Bates Medical Center Labor and Delivery Unit, and cord blood immediately post delivery. Blood samples were kept at 4 1C until centrifuged and serum stored at À 80 1C until analysis. Batched samples of serum 25(OH)D were assayed monthly at ARUP Laboratories (Salt Lake City, UT, USA) using the DiaSorin radioimmunoassay (DiaSorin Inc., Stillwater, MN, USA). An internal standard that had been assayed in duplicate in the laboratory of Dr Bruce Hollis (Medical University of South Carolina, Charleston, SC, USA) was included with each batch and results were adjusted accordingly. Medical records were reviewed to ascertain the length of gestation and infant birth weight.
Mother-infant pairs visited the Children's Hospital & Research Center Oakland's Clinical and Translational Science Institute (CTSI) Clinical Research Center 8-21 days post birth. The length, weight and head circumference of the infants were measured by trained research staff using the World Health Organization's standardized protocol. 12 Weight was measured to the nearest gram using an infant digital scale (Seca 334, Seca Corp., Hamburg, Germany), length to the nearest 0.1 cm on an infant length board (Shorr Infant Polylength Measuring Board, Shorr Productions, Olney, MD, USA), and head circumference to the nearest 0.1 cm (Shorr Productions).
Bone mineral content, bone area and mass were determined by DXA in duplicate using the Hologic Discovery A whole body infant software package (version 12.6.1, Hologic Inc., Waltham, MA, USA). The instrument was calibrated daily using a manufacturer-provided spine phantom. Before imaging, each infant was dressed only in a clean study-provided diaper and swaddled in a cotton receiving blanket to restrict movement. Infants were breast-or formula-fed and pacified immediately before the scan, and the scan with least movement artifact was selected for inclusion in analysis. A single trained technician evaluated the acceptability of all scans and compartmentalized the scan into two regions (head and remainder of body). As the International Society of Clinical Densitometry (ISCD) has no standard for DXA measurements in children under the age 5 years, WBBMC was analyzed raw and adjusted for bone area (BMD) or weight in accordance with the ISCD standards for pediatrics. 13 Size for gestational age at birth was calculated based on fetal growth reference curves with o10th percentile defined as small for gestational age and 490th percentile defined as large for gestational age.
14 Z-scores for infant weight and length were calculated using CDC reference data sets. 15 Seasonal boundaries were based on sine curve analysis of maternal serum 25(OH)D concentrations and were defined as 21 January-20 April, 21 April-20 July, 21 July-20 October, and 21 October-20 January as described previously. 11 
Statistical analysis
Statistical analysis was performed using SAS software (version 9.1, SAS Institute Inc., Cary, NC, USA). Data are presented as means±s.d. 25(OH)D was analyzed both as a continuous and categorical variable. Normality of study variables was tested using the Shapiro-Wilk statistic. Regression models including the quadratic term of the variable of interest were used to test for threshold effects. Path analysis was conducted to identify contributors to the effect of anthropometrics on WBBMC. Differences in variable means between groups were evaluated by analysis of variance using Tukey's test to correct for multiple comparison. Analysis of covariance was used to construct multivariate models utilizing the backwards elimination method.
RESULTS
Of 143 infants born at term who underwent DXA scans at 8-21 days, 11 were excluded due to poor scan quality and 12 due to missing maternal or cord serum 25(OH)D. The 120 infants included in the analysis (Table 1) did not differ significantly from those who underwent DXA scans but were not included (n ¼ 23), or who were eligible but did not return for the DXA visit (n ¼ 32), in gender, maternal age, parity, or maternal or cord vitamin D status.
Bone mineral content of the infant whole body and body less the head were highly correlated (r ¼ 0.88, Po0.0001), therefore whole-body variables were used in the remainder of the analyses. Infant WBBMC was not significantly correlated with maternal or cord 25(OH)D (Figure 1) 
To reduce multicollinearities and control for infant age in multivariate linear models, weight-for-height and height-for-age Z-scores were substituted for raw anthropometrics. Infant WBBMC was significantly predicted by bone area (Po0.0001) and lengthfor-age (Po0.0001) and weight-for-length (P ¼ 0.0005) Z-scores at the time of the DXA scan, with an overall model R 2 ¼ 0.84. Factors not remaining in the final predictive model were maternal and cord 25(OH)D; maternal height, pre-pregnancy BMI or gestational diabetes; and infant age, length of gestation, size for gestational age and feeding practice. In path analysis, infant age and maternal pre-pregnancy BMI were found to mediate the influence of anthropometrics at the DXA visit on infant WBBMC. Vitamin D status and neonatal bone mineral content DK Dror et al
As WBBMC was most strongly influenced by infant size, adjustments to the independent variable were attempted to create a size-neutral index and further consider a potential influence of vitamin D status. Simple adjustment of WBBMC for infant weight (kg) or bone area (as determined by DXA; BMD) over-or under-adjusted for size differences per analysis of residuals. To best adjust for inter-individual differences in size as determined through logarithmic analysis, WBBMC was divided by weight 1.3 or bone area 1.4 . No significant correlations were observed between size-adjusted infant WBBMC and maternal or cord 25(OH)D. In multivariate modeling of size-adjusted infant WBBMC, anthropometric indicators were significant predictors whereas maternal and cord 25(OH)D were not.
DISCUSSION
In this cohort of multiethnic mother-infant pairs in Oakland, CA (381N), WBBMC in full-term infants at 8-21 days of age was not related to maternal or cord vitamin D status, season of birth, feeding habits or sex but was most strongly influenced by various indices of infant size (bone area, height-for-age and weightfor-age Z-scores) and factors determined to be in the pathway for predicting size (maternal pre-pregnancy BMI and infant age at the time of the scan).
Because of the role that vitamin D has in bone mineralization and the association of mineral accretion and growth early in life with future bone integrity, several investigators have sought to measure the relationship between vitamin D status and in utero or early postnatal bone mineralization. 10, 16 Despite the range in serum 25(OH)D demonstrated in the present study, no significant association was found between maternal or cord 25(OH)D concentration and infant WBBMC. This finding contrasts with that of Weiler et al., 10 in which both maternal and cord plasma 25(OH)D remained significant in a multivariate model predicting WBBMC in term-born Canadian infants o15 days of age, albeit with negative and positive coefficients, respectively. However, in the same study infants who were vitamin D deficient (plasma 25(OH)Do27.5 nmol/l) or born to vitamin D-deficient mothers (plasma 25(OHD)o37.5 nmol/l) were heavier and longer than those who were not. Therefore, it is possible that the difference in results was mediated by an association between vitamin D status and size, which was not found in the present study.
It is possible that the comparatively better vitamin D status of the population included in the present study may have obscured an association between vitamin D status and infant size and bone mineral content. A higher prevalence of maternal and cord serum 25(OH)D concentrations o50 nmol/l has been measured in studies conducted at more northerly latitudes (42% and 35%, respectively, at 461N and 531N in Canada 17 and 60-77% and 52%, respectively, at 601N in Finland   7 ). In adults, variance in body size is accounted for by adjusting bone mineral content for 2-dimensional bone area (areal BMD). In children, BMD is a less valid index due to the dynamic process of bone turnover and rapid growth leading to asynchronies between increase in bone area and bone mineral. 18 Nevertheless, to account for individual size differences among infants, investigators have adjusted WBBMC for bone area or infant weight. 7, 8, 10 In the present analyses, such adjustments were made and the power of the denominator further optimized through logarithmic analysis. Despite adjustments, vitamin D status was unassociated with bone measurements. That anthropometric indices remained significant predictors in the multivariate models of adjusted WBBMC indicates that adjustment of the independent variable for weight or bone area alone did not sufficiently control for inter-individual variances in size.
Limitations of the present study include restricted sample size and inherent difficulty in collecting DXA data in infants. Type II error and the fact that a large percentage of mothers in the study had adequate vitamin D status may have precluded an ability to detect differences in infant WBBMC. Sample size was further limited by the difficulty in restricting movement in young infants during the DXA scan. To minimize movement artifact, infants were tightly swaddled, fed and pacified immediately before the scan, and the better of two scans was included in data analysis. Nonetheless, conducting DXA scans on a larger sample of infants is warranted to rule out a threshold effect of vitamin D status on bone mineralization.
In conclusion, no association was found between early infant WBBMC, raw or adjusted for inter-individual differences in size, and maternal or cord vitamin D status in a multiethnic population in Northern California. 
